These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 6086192

  • 1. Stress, dopaminergic blockade and median eminence-neurointermediate lobe catecholamine depletion: effects on hypothalamic, pituitary and plasma immunoreactive beta-endorphin.
    Lim AT, Smith GC, Clements JA, Funder JW.
    Clin Exp Pharmacol Physiol; 1984; 11(3):221-9. PubMed ID: 6086192
    [Abstract] [Full Text] [Related]

  • 2. Effects of intravenously administered 6-hydroxydopamine on the content of monoamines in the median eminence and neurointermediate lobe of the rat.
    Sheward WJ, Watts AG, Fink G, Smith GC.
    Neurosci Lett; 1985 Apr 09; 55(2):141-4. PubMed ID: 2582316
    [Abstract] [Full Text] [Related]

  • 3. Effect of dopaminergic drugs on hypothalamic and pituitary immunoreactive beta-endorphin concentrations in the rat.
    Locatelli V, Petraglia F, Penalva A, Panerai AE.
    Life Sci; 1983 Oct 24; 33(17):1711-7. PubMed ID: 6314082
    [Abstract] [Full Text] [Related]

  • 4. [The effects of dopamine on the release of immunoreactive beta-endorphin-like peptide from the dispersed cells of the rat neurointermediate lobe].
    Furuki Y, Munemura M, Sakoda Y, Hatada Y, Maeyama M, Matsumura M.
    Nihon Naibunpi Gakkai Zasshi; 1985 Jul 20; 61(7):744-52. PubMed ID: 2998896
    [Abstract] [Full Text] [Related]

  • 5. Stress-induced changes in plasma, pituitary and hypothalamic immunoreactive beta-endorphin: effects of diurnal variation, adrenalectomy, corticosteroids, and opiate agonists and antagonists.
    Lim AT, Funder JW.
    Neuroendocrinology; 1983 Jul 20; 36(3):225-34. PubMed ID: 6300719
    [Abstract] [Full Text] [Related]

  • 6. Dopaminergic agents differentially alter beta-endorphin processing patterns in the rat pituitary neurointermediate lobe.
    Autelitano DJ, Smith AI, Lolait SJ, Funder JW.
    Neurosci Lett; 1985 Aug 16; 59(1):141-6. PubMed ID: 2931629
    [Abstract] [Full Text] [Related]

  • 7. Concomitant dopaminergic and glucocorticoid control of pituitary proopiomelanocortin messenger ribonucleic acid and beta-endorphin levels.
    Autelitano DJ, Clements JA, Nikolaidis I, Canny BJ, Funder JW.
    Endocrinology; 1987 Nov 16; 121(5):1689-96. PubMed ID: 2959468
    [Abstract] [Full Text] [Related]

  • 8. Further studies on the effects of intravenously administered 6-hydroxydopamine on the median eminence of the rat.
    Smith GC, Courtney PG, Wreford NG, Walker MM.
    Brain Res; 1982 Feb 18; 234(1):101-10. PubMed ID: 6800564
    [Abstract] [Full Text] [Related]

  • 9. The hypothalamic paraventricular nucleus: relationship to brain and pituitary pools of vasopressin and oxytocin as compared to dynorphin, beta-endorphin and related opioid peptides in the rat.
    Millan MH, Millan MJ, Herz A.
    Neuroendocrinology; 1984 Feb 18; 38(2):108-16. PubMed ID: 6144057
    [Abstract] [Full Text] [Related]

  • 10. Adrenergic regulation of hypothalamic proenkephalin neurons: evidence for opposite effects in subpopulations terminating in median eminence and neurointermediate pituitary.
    George SR, Roldan L, Haas DA.
    Neuroendocrinology; 1990 Aug 18; 52(2):191-5. PubMed ID: 2125707
    [Abstract] [Full Text] [Related]

  • 11. Effects of acute and chronic haloperidol treatment on the concentrations of immunoreactive beta-endorphin in plasma, pituitary and brain of rats.
    Höllt V, Bergmann M.
    Neuropharmacology; 1982 Feb 18; 21(2):147-54. PubMed ID: 6278359
    [Abstract] [Full Text] [Related]

  • 12. Opioid peptides of the pituitary and hypothalamus: changes in pregnant and lactating rats.
    Petraglia F, Baraldi M, Giarrè G, Facchinetti F, Santi M, Volpe A, Genazzani AR.
    J Endocrinol; 1985 May 18; 105(2):239-45. PubMed ID: 3157762
    [Abstract] [Full Text] [Related]

  • 13. Effects of chronic treatment with haloperidol and bromocriptine on the processing of beta-endorphin to gamma- and alpha-endorphin in discrete regions of the rat pituitary gland and brain.
    Sweep CG, Boersma CJ, Wiegant VM.
    Neuropharmacology; 1990 Jan 18; 29(1):61-8. PubMed ID: 1689470
    [Abstract] [Full Text] [Related]

  • 14. Diabetes induced by streptozocin results in a decrease in immunoreactive beta-endorphin levels in the pituitary and hypothalamus of female rats.
    Forman LJ, Marquis DE, Stevens R, Adler R, Vasilenko P.
    Diabetes; 1985 Nov 18; 34(11):1104-7. PubMed ID: 2931314
    [Abstract] [Full Text] [Related]

  • 15. Distribution of immunoreactive beta-neo-endorphin in discrete areas of the rat brain and pituitary gland: comparison with alpha-neo-endorphin.
    Zamir N, Palkovits M, Brownstein MJ.
    J Neurosci; 1984 May 18; 4(5):1248-52. PubMed ID: 6726330
    [Abstract] [Full Text] [Related]

  • 16. Hyperprolactinemia exerts a negative effect on the beta-endorphin content of the rat neurointermediate pituitary lobe.
    Lamberts SW, Uitterlinden P, Bons EG, Zuiderwijk JM, Verleun T, Oosterom R, Hackeng WH.
    Endocrinology; 1984 Jun 18; 114(6):2349-53. PubMed ID: 6327244
    [Abstract] [Full Text] [Related]

  • 17. Effect of stress on tissue and plasma levels of immunoreactive beta-endorphin in ovariectomized rats primed with oestrogen and progesterone.
    Hulse GK, Coleman GJ.
    J Endocrinol; 1984 Mar 18; 100(3):277-80. PubMed ID: 6321626
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Foot shock analgesia. Lack of correlation with pituitary and plasma immunoreactive-beta-endorphin.
    Lim AT, Wallace M, Oei TP, Gibson S, Romas N, Pappas W, Clements J, Funder JW.
    Neuroendocrinology; 1982 Oct 18; 35(4):236-41. PubMed ID: 6292761
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.